Epidemiology of serogroup C meningococcal disease between 1997 and 2004 in Catalonia;Epidemiología de la enfermedad meningocócica por serogrupo C en Cataluña, 1997-2004

Vacunas

Volumn 6, Issue 2, 2005, Pages 51-55

  Cardenosa N ^a   Dominguez A ^a   Martinez A ^a   Salleras, L ^b,c  

^a Barcelona   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Neisseria meningitidis; Serogroup C meningococcal disease; Vaccination programs

Indexed keywords

EID: 67349214704     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(05)73001-6     Document Type: Article

References (14)

1. Dirección Xeral de Saúde Pública A enfermidade meningocócica en Galicia: Tempada 1995/1996 Bol Epidemiol Galicia 9 1996 1 2
2. Departament de Sanitat i Seguretat Social Programa per a la vacunació antimeningocòccica C conjugada a Catalunya 2000 Generalitat de Catalunya Barcelona
3. S. Fernández, L. Arreaza, I. Santiago, A. Malvar, S. Berrón, J.A. Vázquez, et al. Carriage of a new epidemia strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain Epidemiol Infect 23 1999 349 357
4. L. Salleras, A. Domínguez, and N. Cardeñosa Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine Vaccine 21 2003 729 733
5. L. Salleras, A. Domínguez, and G. Prats Control of serogroup C meningococcal disease by mass vaccination in Catalonia (Spain) Vaccine 17 1999 S56 S60
6. M.C.J. Maiden, and B.G. Spratt Meningococcal conjugate vaccines: new opportunities and new challenges Lancet 354 1999 615 616
7. Institut d'Estadística de Catalunya Estadística de població 1996 1997 Institut d'Estadística de Catalunya Barcelona
8. M.E. Ramsay, N. Andrews, E.B. Kaczmarski, and E. Miller Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England Lancet 357 2001 195 196
9. S.C. Greeff, H.E. Melker, L. Spanjaard, S. Van den Hof, and J. Dankert The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients Ned Tijdschr Geneeskd 147 2003 1132 1135
10. N.E. MacDonald, S.A. Halperin, B.J. Law, B. Forrest, L.E. Danzig, and D.M. Granoff Induction of immunologic memory by conjugated versus plain meningococcal C polysaccharide vaccine in toddlers: a readomized controlled trial JAMA 280 1998 1685 1689
11. P. Richmond, E. Kaczmarski, R. Borrow, J. Findlow, S. Clark, R. MaCann, et al. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine J Infect Dis 181 2000 761 764
12. J. Froeschle, F. Ruben, and McVerry Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults: additional data J Infect Dis 184 2001 116 117
13. R. Borrow, D. Goldbaltt, N. Andrews, P. Richmond, J. Southern, and E. Miller Influence of prior meningococcal C polysaccharide vaccination on the respone and generation of memory after meningococcal C conjugate vaccination in young children J Infect Dis 184 2001 377 380
14. J.A. Vázquez Enfermedad meningocócica y vacunas: un nuevo escenario Vacunas 2 2001 1 4